Delivery Order SPE2DE21D0017-SPE2D626F40M8
- Not listed
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a $5,616.00 delivery order award on October 28, 2025, for the procurement of Alere ID NOW Flu A/B2 Qualified Detect Virus kits. The contract is a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of November 4, 2025. Funding originates from the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for procuring medical...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $6,000 fixed-price delivery order (contract number 4570300225) by the Defense Logistics Agency Medical Supply Chain on December 16, 2025, for Alere ID NOW Flu A/B2 Qualified Detection Virus kits. The order, with an ultimate completion date of December 23, 2025, represents a delivery order issued under an existing indefinite delivery vehicle contract and carries no small business set-aside designation....
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $15,000 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency (DLA) Medical Supply Chain on August 7, 2025, for ID NOW flu diagnostic testing products. The contract, which carries no set-aside designation, indicates open competition and is scheduled for ultimate completion on August 14, 2025. Performance will occur at the vendor's location in Lockhart, Florida. This...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $10,200 delivery order on July 24, 2025, for ID NOW flu tests under contract 4568885102. This fixed-price delivery order with economic price adjustment has an ultimate completion date of July 31, 2025, and will be performed in Lockhart, Florida. The award was made without a set-aside designation, indicating open competition. The funding agency is the Defense Logistics Agency (DLA) Medical Supply Chain,...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a $1,200 fixed-price delivery order with economic price adjustment from the Defense Logistics Agency Medical Supply Chain on April 28, 2025, for ID NOW flu diagnostic tests. The contract, awarded without set-aside designation through open competition, is designated as delivery order 4568059894 and carries an ultimate completion date of May 5, 2025. Performance will be executed at the contractor's location in...
- This is a delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain unit to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide the ID NOW FLU testing system. The $43,200.00 fixed-price contract with economic price adjustment has an ultimate completion date of October 31, 2024. The award does not have a set-aside designation. Abbott Rapid DX North America LLC, doing business as Alere North America LLC, is a major supplier of COVID-19...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $6,360 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency Medical Supply Chain on December 16, 2025, for delivery of ID NOW strip A2 qualification detection mobile lab test kits. The award, which carries an ultimate completion date of December 23, 2025, was issued without a set-aside designation and represents a delivery order against an existing indefinite delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) Medical Supply Chain to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The $2,208.00 fixed-price with economic price adjustment delivery order is for the ID NOW FLU product, which is a medical diagnostic testing device. The contract has an ultimate completion date of May 2, 2025 and was awarded on April 25, 2025. This award is not associated with a set-aside designation. Abbott Rapid DX North...
- This federal contract award, valued at $5,472.00, was issued by the Defense Logistics Agency Troop Support Medical division to Abbott Rapid DX North America LLC, doing business as Alere North America LLC. The award is a delivery order contract for the provision of medical diagnostic equipment and supplies, specifically 4566554944 ! ID NOW FLU kits. This award does not have a set-aside designation. Abbott Rapid DX North America LLC is a subsidiary of the larger parent company, Abbott Laboratories...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $2,400.00 on December 18, 2025, for COVID-19 virus test kits under contract 4570328705. The delivery order, which carries a fixed-price structure with economic price adjustment provisions, is scheduled for ultimate completion by December 30, 2025, and will be performed in Lake Mary, Florida. This award was issued without a set-aside designation and is funded through the Defense...
- SPE2DE21D0017Indefinite Delivery Contract
- SPE2DE21D0017-SPE2D626F40M8Delivery Order
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $6,960.00 on December 18, 2025, for the Alere ID NOW Flu A/B2 Qualifier Detect Virus kit. This fixed-price delivery order with economic price adjustment authority is scheduled for completion by December 26, 2025, and will be performed at the company's Lake Mary, Florida facility. The award was issued without a small business set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain, which supports the Department of Defense's healthcare procurement operations. Abbott Rapid DX specializes in point-of-care diagnostic testing devices and has established itself as a critical supplier of rapid antigen and molecular diagnostic platforms to federal healthcare agencies. This delivery order represents a continuation of Abbott's extensive contracting relationship with federal agencies for diagnostic testing supplies. The company maintains multiple indefinite delivery vehicles across Veterans Integrated Service Networks and the Defense Health Agency, with a portfolio spanning COVID-19 antigen tests, influenza and streptococcus detection devices, chemistry analyzers, and related clinical testing technologies. The ID NOW platform referenced in this award is a molecular diagnostic system widely utilized across federal healthcare networks for rapid viral and bacterial detection. Abbott's sustained federal contracting presence reflects its competitive positioning in the clinical diagnostics market and the government's reliance on its sophisticated point-of-care testing capabilities to support military medical readiness and healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 12/17/25 |